Focal segmental glomerulosclerosis in a patient with prefibrotic primary myelofibrosis
暂无分享,去创建一个
G. Bohra | D. Meena | A. Purohit | N. Bajpai
[1] A. Tefferi,et al. Primary myelofibrosis: 2017 update on diagnosis, risk‐stratification, and management , 2016 .
[2] S. Verstovsek,et al. Primary myelofibrosis associated glomerulopathy: significant improvement after therapy with ruxolitinib , 2015, BMC Nephrology.
[3] V. D’Agati,et al. Myeloproliferative neoplasms cause glomerulopathy. , 2011, Kidney international.
[4] F. Cakalagaoglu,et al. Focal Segmental Glomerulosclerosis Associated with Idiopathic Myelofibrosis , 2010, Renal failure.
[5] S. Shankland,et al. The cyclin-dependent kinase inhibitor p21 is required for TGF-β1-induced podocyte apoptosis , 2005 .
[6] H. Kwak,et al. CT findings of extramedullary hematopoiesis in the thorax, liver and kidneys, in a patient with idiopathic myelofibrosis. , 2000, Journal of Korean medical science.
[7] P. Wollan,et al. Population‐based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: An Olmsted county study, 1976–1995 , 1999, American journal of hematology.
[8] Y. Erzin,et al. Secondary amyloidosis in the course of idiopathic myelofibrosis. , 1997, Leukemia research.
[9] J. Oesterling,et al. Idiopathic myelofibrosis with myeloid metaplasia involving the renal pelves, ureters and bladder. , 1992, The Journal of urology.